摘要
对比后腹腔入路与经腹腔入路腔镜肾上腺肿瘤切除术治疗肾上腺肿瘤的效果。选取2023年1月—2025年1月兰州大学第一医院收治的100例肾上腺肿瘤患者为研究对象,随机将其分为对照组和观察组,每组各50例。对照组行经腹腔入路腹腔镜肾上腺肿瘤切除术(transperitoneal laparoscopic adrenalectomy,TLA),观察组行后腹腔入路腹腔镜肾上腺肿瘤切除术(retroperitoneal laparoscopic adrenalectomy,RLA)。对比两组患者的手术指标、免疫功能指标、应激指标和并发症发生情况。结果显示,观察组术中出血量少于对照组,手术时间、术后首次进食时间均短于对照组(P<0.05);术后,观察组CD4^(+)、CD8^(+)、CD4^(+)/CD8^(+)水平均低于对照组(P<0.05);观察组并发症发生率低于对照组(P<0.05)。研究发现,TLA及RLA治疗肾上腺肿瘤均可获得良好效果,但RLA手术时间更短,患者术后恢复速度更快,且其对机体免疫功能影响更小,更具安全性。
This study aimed to compare the efficacy of retroperitoneal laparoscopic adrenalectomy(RLA)and transperitoneal laparoscopic adrenalectomy(TLA)in the treatment of adrenal tumors.A total of 100 patients with adrenal tumors admitted to the First Hospital of Lanzhou University from January 2023 to January 2025 were selected as research subjects and randomly divided into a control group and an observation group,with 50 cases in each group.The control group underwent TLA,while the observation group received RLA.The surgical indicators,immune function indices,stress indices,and complication rates were compared between the two groups.Results showed that the observation group had less intraoperative blood loss,shorter operation time,and earlier first postoperative feeding time than the control group(P<0.05).Postoperatively,the levels of CD4^(+),CD8^(+),and CD4^(+)/CD8^(+)in the observation group were lower than those in the control group(P<0.05).The complication rate in the observation group was lower than that in the control group(P<0.05).The study concluded that both TLA and RLA achieve favorable outcomes in treating adrenal tumors.However,RLA offers shorter operation time,faster postoperative recovery,less impact on immune function,and higher safety,making it more advantageous.
作者
方程
李文辉
刘莎莎
Fang Cheng;Li Wenhui;Liu Shasha(Department of Urology,the First Hospital of Lanzhou University,Lanzhou,Gansu 730000;Department of Pathology,the First Hospital of Lanzhou University,Lanzhou,Gansu 730000)
出处
《科技与健康》
2025年第13期61-64,共4页
Technology and Health
基金
甘肃省自然科学基金(25JRRA562)。
